Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

NICE has said it expects to evaluate dozens of potential treatments for Alzheimer’s disease over the next few years. Elisabeth Mahase examines what we know about these drugs This year the National ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

A groundbreaking research conducted in France has unveiled compelling evidence linking caffeine consumption to reduced ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

They discovered that patients who were prescribed semaglutide (the active ingredient in Ozempic and Wegovy) had a "significantly" lower risk of developing Alzheimer’s disease compared to people who ...

Find out what AI has already brought to Alzheimer's disease research and most importantly, what it can accomplish in the ...